Lynx dx medical in Michigan

Lynx Dx, Inc. is a health institution located at 5230 South State Road in Ann Arbor, Michigan, United States. Specializing in informed prostate cancer risk screening, Lynx Dx offers MPS2, a non-invasive urine test that provides a new level of simple, actionable, and data-driven decision making for providers and patients. This test analyzes urine in an array of 18 genetic biomarkers, including T2:ERG, to accurately predict the risk for prostate cancer with 95%-99% accuracy. The institution aims to provide a solution with zero surprises and peace of mind for all involved, offering personalized biomarker testing for patients who have had prior negative biopsies. With a focus on early detection and personalized healthcare decisions, Lynx Dx is dedicated to supporting positive public health and helping individuals live healthy lives. MyProstateScore 2.0 is a valuable tool in the fight against prostate cancer, providing accurate data to assist urologists and patients in making informed decisions about their health.